Regression of Hodgkin lymphoma in response to antiviral therapy for hepatitis C virus infection | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Regression of Hodgkin lymphoma in response to antiviral therapy for hepatitis C virus infection

Takahashi K, Nishida N, Kawabata H, Haga H, Chiba T. Regression of Hodgkin lymphoma in response to antiviral therapy for hepatitis C virus infection. Intern Med. 2012;51(19):2745-2747.

Publication Type:

Journal Article

Authors:

Takahashi, K.; Nishida, N.; Kawabata, H.; Haga, H.; Chiba, T.

Source:

Intern Med, Volume 51, Issue 19, p.2745-2747 (2012)

Keywords:

Antiviral Agents, Case Report, complications, drug therapy, Gastroenterology, HCV, hepatitis, Hepatitis C, hepatitis C virus, Hepatitis C,Chronic, Hodgkin Disease, Humans, Infection, Interferon-alpha, Japan, Lymphoma, Male, Medicine, Middle Aged, pathology, peginterferon, Polyethylene Glycols, Proteins, PROVIDE, radiography, Recombinant Proteins, Remission Induction, Ribavirin, therapeutic use, therapy, Tomography,X-Ray Computed

Cited On:

When and in Whom to Initiate HCV Therapy

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/23037466

Export Citation:

RIS Format

Top